Skip to Main Content

Paper Details

Systemic Sirolimus to Prevent In-Stent Stenosis in Pediatric Pulmonary Vein Stenosis.
Pediatr Cardiol
21
2020
ISS, PVS, Pulmonary Vein Stenosis, Sirolimus, TAPVC, complex heart disease, congenital heart disease, intraluminal pulmonary vein stenosis, patient, patients, pneumonia, rapamycin, sirolimus
Aged, Child, Preschool, Constriction, Pathologic, Female, Humans, Immunosuppressive Agents, Infant, Male, Middle Aged, Retrospective Studies, Sirolimus, Stenosis, Pulmonary Vein, Stents, Treatment Outcome
Author NameAffiliation
Ryan CallahanBoston Children's Hospital and Harvard Medical School
Jesse J EschBoston Children's Hospital and Harvard Medical School
Grace WangBoston Children's Hospital and Harvard Medical School
Christina IrelandBoston Children's Hospital and Harvard Medical School
Kimberlee GauvreauBoston Children's Hospital and Harvard Medical School
Kathy J JenkinsBoston Children's Hospital and Harvard Medical School
  • 1 - 6

Datasets